Pulse Biosciences

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$1,740
Gross Profit
-266
-299
1,436
EBITDA
-11,460
-10,316
-12,229
EBIT
-11,726
-10,615
-12,533
Net Income
-11,383
-10,137
-11,933
Net Change In Cash
0
0
1,740
Free Cash Flow
-8,424
-9,785
-6,819
Cash
26,196
34,885
44,365
Basic Shares
57,180
55,172
55,058

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$-9
$700
$1,418
$114
Gross Profit
-1,207
-11,244
-550
-665
EBITDA
-42,367
-56,702
-61,868
-49,300
EBIT
-43,574
-58,057
-63,014
-50,395
Net Income
-42,210
-58,953
-63,160
-49,737
Net Change In Cash
-9
700
1,418
114
Cost of Revenue
5,564
Free Cash Flow
-33,161
-47,414
-54,534
-35,806
Cash
44,365
61,139
28,614
12,463
Basic Shares
48,038
33,935
27,964
23,248

Earnings Calls

Quarter EPS
2024-09-30
-$0.20
2024-06-30
-$0.19
2024-03-31
-$0.18
2023-12-31
-$0.21